491 related articles for article (PubMed ID: 30800120)
1. The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.
Patel SY; Carbone J; Jolles S
Front Immunol; 2019; 10():33. PubMed ID: 30800120
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of immunoglobulin replacement therapy in patients with secondary antibody deficiency.
Patel V; Cowan J
Expert Rev Clin Immunol; 2020 Jul; 16(7):711-716. PubMed ID: 32588670
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of Specific Antibody Deficiency.
Perez EE; Ballow M
Immunol Allergy Clin North Am; 2020 Aug; 40(3):499-510. PubMed ID: 32654695
[TBL] [Abstract][Full Text] [Related]
4. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees.
Otani IM; Lehman HK; Jongco AM; Tsao LR; Azar AE; Tarrant TK; Engel E; Walter JE; Truong TQ; Khan DA; Ballow M; Cunningham-Rundles C; Lu H; Kwan M; Barmettler S
J Allergy Clin Immunol; 2022 May; 149(5):1525-1560. PubMed ID: 35176351
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma.
Giralt S; Jolles S; Kerre T; Lazarus HM; Mustafa SS; Papanicolaou GA; Ria R; Vinh DC; Wingard JR
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):719-732. PubMed ID: 37353432
[TBL] [Abstract][Full Text] [Related]
6. Antibody replacement therapy in primary antibody deficiencies and iatrogenic hypogammaglobulinemia.
Hoffman TW; van Kessel DA; van Velzen-Blad H; Grutters JC; Rijkers GT
Expert Rev Clin Immunol; 2015; 11(8):921-33. PubMed ID: 26181342
[TBL] [Abstract][Full Text] [Related]
7. Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.
Duraisingham SS; Buckland M; Dempster J; Lorenzo L; Grigoriadou S; Longhurst HJ
PLoS One; 2014; 9(6):e100324. PubMed ID: 24971644
[TBL] [Abstract][Full Text] [Related]
8. Secondary Hypogammaglobulinemia: An Increasingly Recognized Complication of Treatment with Immunomodulators and After Solid Organ Transplantation.
Kaplan B; Bonagura VR
Immunol Allergy Clin North Am; 2019 Feb; 39(1):31-47. PubMed ID: 30466771
[TBL] [Abstract][Full Text] [Related]
9. Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells.
Edwards ESJ; Bosco JJ; Aui PM; Stirling RG; Cameron PU; Chatelier J; Hore-Lacy F; O'Hehir RE; van Zelm MC
Front Immunol; 2019; 10():2593. PubMed ID: 31803177
[No Abstract] [Full Text] [Related]
10. Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET).
Syed MN; Kutac C; Miller JM; Marsh R; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Kheradmand F; Hajjar J
J Clin Immunol; 2022 Oct; 42(7):1545-1552. PubMed ID: 35779201
[TBL] [Abstract][Full Text] [Related]
11. Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
Dhalla F; Lucas M; Schuh A; Bhole M; Jain R; Patel SY; Misbah S; Chapel H
J Clin Immunol; 2014 Apr; 34(3):277-82. PubMed ID: 24557494
[TBL] [Abstract][Full Text] [Related]
12. Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia.
Ohmoto A; Fuji S; Shultes KC; Savani BN; Einsele H
Bone Marrow Transplant; 2022 Jun; 57(6):874-880. PubMed ID: 35440805
[TBL] [Abstract][Full Text] [Related]
13. Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.
Na IK; Buckland M; Agostini C; Edgar JDM; Friman V; Michallet M; Sánchez-Ramón S; Scheibenbogen C; Quinti I
Eur J Haematol; 2019 Jun; 102(6):447-456. PubMed ID: 30801785
[TBL] [Abstract][Full Text] [Related]
14. Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives.
Ar MC; El Fakih R; Gabbassova S; Alhuraiji A; Nasr F; Alsaeed A; Sayinalp N; Marashi M
Leuk Res; 2023 Oct; 133():107365. PubMed ID: 37643508
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.
Link H; Kerkmann M; Holtmann L; ;
Support Care Cancer; 2022 Jun; 30(6):5187-5200. PubMed ID: 35257229
[TBL] [Abstract][Full Text] [Related]
17. Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency.
Weinberger T; Fuleihan R; Cunningham-Rundles C; Maglione PJ
J Clin Immunol; 2019 May; 39(4):440-447. PubMed ID: 31089938
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review.
Wijetilleka S; Mukhtyar C; Jayne D; Ala A; Bright P; Chinoy H; Harper L; Kazmi M; Kiani-Alikhan S; Li C; Misbah S; Oni L; Price-Kuehne F; Salama A; Workman S; Wrench D; Karim MY
Autoimmun Rev; 2019 May; 18(5):535-541. PubMed ID: 30844552
[TBL] [Abstract][Full Text] [Related]
19. Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.
Wasserman RL
Immunol Allergy Clin North Am; 2019 Feb; 39(1):95-111. PubMed ID: 30466775
[TBL] [Abstract][Full Text] [Related]
20. When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.
Jolles S; Chapel H; Litzman J
Clin Exp Immunol; 2017 Jun; 188(3):333-341. PubMed ID: 28000208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
